全文获取类型
收费全文 | 709篇 |
免费 | 38篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 34篇 |
妇产科学 | 4篇 |
基础医学 | 77篇 |
口腔科学 | 28篇 |
临床医学 | 55篇 |
内科学 | 119篇 |
皮肤病学 | 5篇 |
神经病学 | 148篇 |
特种医学 | 109篇 |
外科学 | 21篇 |
综合类 | 9篇 |
预防医学 | 38篇 |
眼科学 | 46篇 |
药学 | 26篇 |
中国医学 | 2篇 |
肿瘤学 | 44篇 |
出版年
2019年 | 13篇 |
2018年 | 9篇 |
2017年 | 9篇 |
2016年 | 11篇 |
2015年 | 13篇 |
2014年 | 9篇 |
2013年 | 29篇 |
2012年 | 9篇 |
2011年 | 17篇 |
2010年 | 26篇 |
2009年 | 36篇 |
2008年 | 16篇 |
2007年 | 27篇 |
2006年 | 16篇 |
2005年 | 14篇 |
2004年 | 27篇 |
2003年 | 13篇 |
2002年 | 20篇 |
2001年 | 11篇 |
2000年 | 18篇 |
1999年 | 18篇 |
1998年 | 35篇 |
1997年 | 36篇 |
1996年 | 33篇 |
1995年 | 31篇 |
1994年 | 26篇 |
1993年 | 24篇 |
1992年 | 11篇 |
1991年 | 16篇 |
1990年 | 10篇 |
1989年 | 19篇 |
1988年 | 20篇 |
1987年 | 15篇 |
1986年 | 19篇 |
1985年 | 16篇 |
1984年 | 9篇 |
1983年 | 8篇 |
1982年 | 16篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1979年 | 3篇 |
1978年 | 4篇 |
1977年 | 2篇 |
1976年 | 5篇 |
1975年 | 9篇 |
1973年 | 2篇 |
1972年 | 4篇 |
1970年 | 2篇 |
1969年 | 3篇 |
1966年 | 4篇 |
排序方式: 共有766条查询结果,搜索用时 15 毫秒
1.
Jean-Fran ois Marini Fran oise Pons Jocelyne Leger Nathalie Loffreda Monique Anoal Martine Chevallay Michel Fardeau Jean J. Leger 《Neuromuscular disorders : NMD》1991,1(6):397-409
The expression of MHC isoforms in the skeletal muscles of nine patients with Duchenne muscular dystrophy (DMD) (from 2.5 to 15 yr of age) and three DMD carriers was studied using different specific anti-MHC MAbs. We also analyzed muscle fiber size and fiber reactivity with acridine orange and/or with a surface antigen marker. One-quarter of all fibers of DMD patients, or less with age, were of normal size and contained only adult slow MHC. Half of the muscle fibers contained adult and developmental MHCs. Only half of these fibers were representative of an active regenerative process. MHC co-expression also altered the proportion of normal fast or slow fibers. Adult fast MHCs were expressed as unique MHC only in small and very small fibers in the oldest DMD patients. In DMD carrier muscles, the greatest alterations in MHC expression were observed in patients with the most reduced dystrophin expression. However, MHC changes in dystrophin-positive fibers were similar to those observed in dystrophin-free fibers. In conclusion, disruptions or delays in the switching of all genes coding for adult fast and slow MHC and developmental MHC coincided with dystrophin deletion and with perturbations in its expression. 相似文献
2.
3.
Mitochondrial function and mitochondrial DNA in a series of 64 patients suspected of having mitochondrial myopathy 总被引:1,自引:0,他引:1
C Marsac F Degoul G Bonne N Romero I Nelson M Fardeau D Fran?ois G Ponsot J P Harpey B Eymard 《Revue neurologique》1991,147(6-7):462-466
Biochemical results concerning 64 patients suspected of mitochondrial myopathies are presented. Four clinical groups were studied including 21 encephalomyopathies, 42 ocular myopathies, 8 isolated myopathies and 3 cardiomyopathies. In 26 cases, the coexistence of a normal mitochondrial DNA and a mutated mitochondrial DNA (heteroplasmy) was found (19 simple deletions, 4 multiple deletions and 3 punctual mutations) and all cases presented with ocular disorders (excepted 2 cases with MERRF). Furthermore, 1 complex I deficiency (1 ocular myopathy), 1 complex IV deficiency (1 adult encephalomyopathy type Leigh), 3 complexes I + IV deficiencies (2 cases with a cardiomyopathy and 1 familial MELAS) and 2 pyruvate (1 adult from of Leigh's encephalomyopathy) dehydrogenase deficiencies (clinically and genetically different) did not show evidence of mitochondrial DNA mutation. 相似文献
4.
5.
In vitro myotrophic effect of serum kappa chain immunoglobulins from a patient with kappa light chain myeloma and muscular hypertrophy. 下载免费PDF全文
C Delaporte B Varet M Fardeau D Nochy A Ract 《The Journal of clinical investigation》1986,78(4):922-927
Muscle hypertrophy due to enlarged muscle fibers was accompanied by kappa light chain myeloma in a 62-yr-old man. Immunofluorescence showed kappa light chain deposits around muscle fibers. We hypothesized that a circulating growth factor may be involved in the pathogeny of this muscular hypertrophy. Patient serum cultured with muscle cells showed that (a) the patient's serum exhibited a trophic effect on human muscle cells in culture, (b) this trophic effect increased the differentiation and did not influence the proliferation of human muscle cells, and (c) the fraction of the patient's serum immunoadsorbed on antihuman kappa chain antibodies exhibited the same in vitro effect on the muscle cells, whereas the fraction immunoadsorbed on antihuman lambda chain antibodies did not. These results support the hypothesis that the patient's kappa light chains have a specific enhancing effect on human muscle cell differentiation, perhaps leading to an acquired muscular hypertrophy. 相似文献
6.
Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience 总被引:14,自引:0,他引:14
7.
8.
Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). 总被引:2,自引:1,他引:2 下载免费PDF全文
A Carrié F Piccolo F Leturcq C de Toma K Azibi C Beldjord J M Vallat L Merlini T Voit C Sewry J A Urtizberea N Romero F M Tomé M Fardeau Y Sunada K P Campbell J C Kaplan M Jeanpierre 《Journal of medical genetics》1997,34(6):470-475
Sarcoglycanopathies are a genetically heterogeneous group of autosomal recessive muscular dystrophies in which the primary defect may reside in any of the genes coding for the different partners of the sarcolemmal sarcoglycan (SG) complex: the alpha-SG (LGMD2D at 17q21.2), the beta-SG (LGMD2E at 4q12), the gamma-SG (LGMD2C at 13q12), and the delta-SG (LGMD2F at 5q33). We report a series of 20 new unrelated families with 14 different mutations in the alpha-SG gene. Along with the mutations that we previously reported this brings our cohort of patients with alpha-sarcoglycanopathy to a total of 31 unrelated patients, carrying 25 different mutations. The missense mutations reside in the extracellular domain of the protein. Five of 15 missense mutations, carried by unrelated subjects on different haplotype backgrounds and of widespread geographical origins, account for 58% of the mutated chromosomes, with a striking prevalence of the R77C substitution (32%). The severity of the disease varies strikingly and correlates at least in part with the amount of residual protein and the type of mutation. The recurrent R284C substitution is associated with a benign disease course. 相似文献
9.
Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva (FOP) 总被引:1,自引:0,他引:1
Xu MQ Feldman G Le Merrer M Shugart YY Glaser DL Urtizberea JA Fardeau M Connor JM Triffitt J Smith R Shore EM Kaplan FS 《Clinical genetics》2000,58(4):291-298
Fibrodysplasia ossificans progressiva (FOP) is an extremely rare and disabling genetic disorder characterized by congenital malformation of the great toes and by progressive heterotopic endochondral ossification in predictable anatomical patterns. Although elevated levels of bone morphogenetic protein 4 (BMP4) occur in lymphoblastoid cells and in lesional cells of patients with FOP, mutations have not been identified in the BMP4 gene, suggesting that the mutation in FOP may reside in a BMP4-interacting factor or in another component of the BMP4 pathway. A powerful antagonist of BMP4 is the secreted polypeptide noggin. A recent case report described a heterozygous 42-bp deletion in the protein-coding region of the noggin gene in a patient with FOP. In order to determine if noggin mutations are a widespread finding in FOP, we examined 31 families with 1 or more FOP patients. Linkage analysis with an array of highly polymorphic microsatellite markers closely linked to the noggin gene was performed in four classically-affected multigenerational FOP families and excluded linkage of the noggin locus to FOP (the multipoint lod score was -2 or less throughout the entire range of markers). We sequenced the noggin gene in affected members of all four families, as well as in 18 patients with sporadic FOP, and failed to detect any mutations. Single-strand conformation polymorphism (SSCP) analysis of 4 of these patients plus an additional 9 patients also failed to reveal any mutations. Among the samples analyzed by SSCP and DNA sequencing was an independently obtained DNA sample from the identical FOP patient previously described with the 42-bp noggin deletion; no mutation was detected. Examination of the DNA sequences of 20 cloned noggin PCR products, undertaken to evaluate the possibility of a somatic mutation in the noggin gene which could be carried by a small subset of white blood cells, also failed to detect the presence of the reported 42-bp deletion. We conclude that mutations in the coding region of noggin are not associated with FOP. 相似文献
10.